Literature DB >> 26322328

Micronutrient in hyperphenylalaninemia.

Vanesa Crujeiras1, Luís Aldámiz-Echevarría2, Jaume Dalmau3, Isidro Vitoria3, Fernando Andrade2, Iria Roca4, Rosaura Leis1, Ana Fermandez-Marmiesse5, María L Couce5.   

Abstract

The data presented here are the biochemical parameters of 156 patients with hyperphenylalaninemia. PKU patients, who, in order to maintain optimal serum Phe concentrations, receive dietary treatment consisting of a diet low in natural protein supplemented with special low protein foods and a Phe-free amino acid mixture, vitamins and minerals. The obtained data reflects a high percentage of patients with prealbumin and selenium deficiencies, as well as an increased level of folic acid. This data article is related to the research article entitled, "Vitamin and mineral status in patients with hyperphenylalaninemia", by Crujeiras et al. [1].

Entities:  

Year:  2015        PMID: 26322328      PMCID: PMC4543207          DOI: 10.1016/j.dib.2015.07.026

Source DB:  PubMed          Journal:  Data Brief        ISSN: 2352-3409


Data, experimental design, materials and methods

The population comprised PKU patients from three Spanish Centers: Hospital Universitario La Fe-Valencia, Hospital Universitario de Cruces-Basque Country and Hospital Clínico Universitario de Santiago-Galicia. Patients were followed in their center from diagnosis to date. We included both patients diagnosed by newborn screening as well as those diagnosed later. Those who underwent sporadic monitoring were excluded, as well as those cases in which informed consent was not signed by parents and/or patients. The variables collected for each patient were: age, sex, phenotype (mild hyper-Phe (MHPA) 120–360 μmol/L; mild-moderate PKU 360–1200 μmol/L (MPKU); classic PKU>1200 μmol/L (CPKU) (according to US Guidelines [2], disease detection (early and late diagnosis), annual median blood Phe levels (target blood Phe levels considered adequate for children under 6 years of age were <360 µmol/L; <480 µmol/L between 6 and 10 years and ≤600 µmol/L in older patients), anthropometric measurements (weight, height and BMI), phenylalanine tolerance and BH4 treatment in the BH4 responsive patients; blood chemistry (total protein, prealbumin, electrolytes, selenium (Se), zinc (Zn), B12, folic acid, ferritine, 25-hydroxy vitamin D (25-OHD). Micronutrients levels evaluated present the following reference intervals (valid for any patient age): Total protein: 6.3–8.5 g/dL; calcium (Ca): 8.7–10.8 mg/dL; phosphorus (P): 2,6-5.9 mg/dL, prealbumin: 21–41 mg/dL; vitamin B12: 180–1900 pg/mL; folic acid: 3–17.5 ng/mL; 25-OHD: 20–42 ng/mL; ferritin: 14–325 ng/mL; Zn: 65–140 µg/dL; Se: 60–125 µg/L

Data

In PKU patients, micronutrient deficiencies but no clinical symptoms have been reported, mainly for Zn, Se, Fe, folate and B12 [3-5]. In this study 127 patients had altered values in one or several markers evaluated (Table 1), 58.33% were from CPKU, 21.67% from MPKU and 20% from MHPA patients. Interestingly, from these patients with altered values, the 84.16% had adequate adherence to diet.
Table 1

Characteristics of Hyperphenylalaninaemia patients with values of the biochemical parameters studied.

PSexAgeBMIDiagTre. D/TTDPhe tol mg/dPhe median µMProt g/dLPrealb mg/dLCa mg/dLP mg/dLFer ng/mLB12 pg/mLFolic ng/mL25-OHD ng/mLZn µg/dLSe µg/dL
1F2y 11mNCPKUDE3451386.618↓9.95.613585324↑409947↓
2M19y 3mCPKUDL2173807.9259.83.33682324↑38.711774
3M2y 7mNCPKUDE223258717↓105.62978915.140.276.5106
4F2y 7m↑↑CPKUDE2181236.414↓10.25.630444132656.6↓38.6↓
5M18y 2mNCPKUDE4694087.53010.13.93772324↑37.478.532.3↓
6M28y 9mCPKUDE36710327.53610.24322728.625.511952.7↓
7F1y 2mCPKUDE1181626.514↓9.248469618.7↑36.281.568.7
8F15y 2mNCPKUDE4544807.72810.4412640517.319.1↓7070
9F2y 4mCPKUDE243906.716↓10.15.22893418.5↑4078.562.5
10F13y 1m↑↑CPKUDE3904746.8229.65.25↓34724↑34.482.569.5
11F3y 3mNCPKUDE289225714↓10.34.74083513.229.359.7↓19.6↓
12M4y 10mNCPKUDE3792076.817↓105.12846217.227.810662
13F92y 7mCPKUDE4405226.6349.33.94098020↑41.3145↑69.5
14F9y 6mNCPKUDE1533007.519↓10.14.95261716.926.471.557↓
15M7yNCPKUD/TE11623366.72110.44.53477918.6↑48↑76.568.7
16M2y 6mCPKUDE4733486.4229.852146824↑40.676.558.7↓
17F15y 6mNCPKUDE4474507.719↓104.6323885.6827.210171
18M39yCPKUDE2057776.5319.42.3↓8935416.527.611351.7↓
19M5y 8m↑↑CPKUDE2423306.9309.34.54076112248036.1↓
20M3y 2m↑↑CPKUDE1942046.82110.19.9↑2456034.278.5
21F14y 9mCPKUDE4323666.918↓10.13.84842116.728.76557↓
22M2y 9mNCPKUDE4482436.620↓10.14.83265620.2↑31.978.534↓
23M18y 10mNCPKUDL5032527.6269.94.89.9↓82416.936.910368.7
24F23y 11mCPKUDE3203817.4289.33.56162816.341.3144↑68.7
25M3y 9mCPKUDE3814446.1↓19↓9.85.99783824↑32.212568.7
26F34y 9m↑↑CPKUDE40911587.7219.63395246.430.412040.18↓
27M5y 10mCPKUDE4252587.216↓9.6513↓67515.119↓73.574.9
28F30y 4mNCPKUDE7719726.4218.5↓2.72230111.520.275.5
29M3y 7mNCPKUDE2261926.316↓10.75.98↓67916.336.580.568.7
30M23yCPKUDE2568467.23710.12.3↓9147114.441.9145↑77.2
31M9mNCPKUDE250906.420↓10.36.4↑267120117.237.5170↑77.2
32F17y 4m↑↑CPKUDL1695766.8229.83.32393724↑2075.549.4↓
33M10y 6mNCPKUDE551566.417↓9.83.31274231631.89371
34F6y 4mNCPKUDE5371567.320↓10.45.54260014.34271.5135↑
35M5y 11mCPKUDE4031386.518↓9.95.12437216.952↑74.5124
36M5y 1mNCPKUDE4893846.719↓104.527187518.5↑43.2↑7754.8↓
37M42y 6mCPKUDL1218887.6249.27366030↑2669.260
38F5y 5m↑↑MPKUD/TE10691986.718.4↓103550130↑3387.342↓
39F4y 1mNMPKUDE438117722.810.23476628↑3667.248↓
40M26y 4mMPKUDE430300719.1↓91085819.4417↓76.870
41M3yNMPKUDE3121507.222.69.93066921.1↑3810844↓
42F19y 9mNMPKUDE15218827.542↑10.21338721.6↑339573
43M3y↑↑MPKUDE435174726.310.296717.6↑279879
44M36yNCPKUDL4016637.825.79.411↓2000↑28↑297184
45M4y 6mNCPKUDE3602946.714.5↓9.71573728↑397366
46F43y 1mCPKUDL4385166.926.69.436818.45↑307556↓
47F12y 1mNMPKUDE5871326.920.2↓9.629013.72286873
48F8y 5mNMPKUDE2451927.117.2↓9.858224↑216558↓
49M9y 4mNCPKUDE5522647.229.19.92361624↑258564
50M44y 11mNCPKUDL2998977.2349.83.55230213.416.1↓59↓50↓
51F41y 8mNCPKUDL7657517.5299.62.61548243.9↑207370
52M39y 11mCPKUDL6008167.626103.14069828.9↑277758↓
53F39y 6mNCPKUDL6923007.3259.32.922176732.5↑277454↓
54F38y 2m↑↑MPKUDL4787667.12410.13.24240124↑228467
55F34y 11mNCPKUDE4504906.720↓9.83.32525817.9↑11↓7052↓
56M32y 2mCPKUDL5056967.9239.82.72173022.01↑17↓7153↓
57M32y 1mCPKUDL9624227.63210.42.682103149.6↑2898122
58F31y 11mNCPKUDL4816797.8269.92.82383232.6↑247183
59M30y 7m↑↑CPKUDE8006957.63610.22.711449538.8↑18↓8583
60M28y 6mMPKUD/TE2294527.7349.93.620357130.6↑21.58486
61F24y 11mCPKUDE7303887.228102.3↓2239119.7↑44↑63↓58↓
62F23y 8mNCPKUDE2374317.5289.82.618126622.2↑17↓7982
63F20y 11m↑↑CPKUDE5113707.32910.24.69043531.1↑306677
64M20y 9mCPKUDE3126137.72910.27.7↑24660016.52710145↓
65M19y 4mNCPKUDE7005676.420↓10.43.23377.933104
66F19y 7mNMPKUD/TE30512627.2379.943258420.6↑316776
67F19y 3m↑↑MPKUD/TE4611977.72810.33.71441910.417↓7587
68F18y 8mMPKUDE221243783310.13.43760529.1↑19.2↓7471
69F17y 4mMPKUD/TE8022617.344↑10.43.3214075.9319670
70M16y 8mNMPKUDE15006807.63110.53465218.5257651↓
71M15y 4mMPKUD/TE25852317.320↓10.24.84058916.7217469
72F15y 9mNMPKUD/TE2402777.1299.93.510↓47621.1↑2410086
73F14y 10m↑↑CPKUDE3144277.82910.14457259.7239245↓
74F14y 8mNCPKUDE20003888.3349.84.12195920.5↑2310574
75F14y 5mNMPKUD/TE5131998279.83.31758312.918↓7571
76M13y 5mNCPKUDE2602277.818↓10.1443118911.1338374
77F12y 8mCPKUDE3993637.72510.14.53991131↑288671
78M10y 6mCPKUDE2614307.12310.33.829106032.4↑318054↓
79M11y 5m↑↑CPKUDE5213107.62310.851792022.9↑337449↓
80M11y 4m↑↑MPKUDE5242747.73411↑3.22359819.8↑429451↓
81M11yNCPKUDE148191719↓10.24.332119216.2279484
82F9y 9m↑↑MPKUDE12501967.32310.44.27554130.4↑388375
83M8yNMPKUD/TE3522026.820↓10.15.12978817.5367363
84M7y 10m↑↑CPKUDE8721716.415↓9.24.33968724↑299256↓
85F7y 8m↑↑MPKUD/TE9001617.319↓9.84.33583334.1↑267669
86F7y 8m↑↑MPKUD/TE4571557.118↓9.84.54686530.8↑46↑7472
87M7y 2mNCPKUDE8151607239.5428113438.4↑14↓9163
88F5y 7mMPKUD/TE3802666.620↓9.95.3372538.79568
89F5y 6mNCPKUDE10501627.714↓104.183129332.5↑259186
90F4yNMPKUD/TE2641956.920↓10.45.76↓74811.5266675
91M3y 8mNMPKUDE165179715↓9.74.24286836.8↑246749↓
92F1y 10mNCPKUDE174937.113↓10.15.32794726.9↑229859↓
93M1y 4mNCPKUDE3197872510.25.52977430.7↑19↓11052↓
94F1y 4m↑↑CPKUDE259986.316↓10.15.51854823.4↑2711340↓
95M9mCPKUDE2222226.814↓10.75.625188217.532131
96M7mNCPKUDE7502046.82110.65.72262321↑259150↓
97M1y 11mNHPAE26012506.918↓10.24.92329010.118.7↓7373
98F5y 8mNHPAE30002587.5219.94.51854513.417↓8261
99F15y 2mNHPAE27002808239.83.66↓730297476
100F6y 7mHPAE26002407.1279.65.12254210.817.3↓6895
101F9yNHPAE24002707.420↓10.14.85747418.8↑306767
102F8yHPAE19002307.52410.24.12163817.518↓101100
103F4y 8mNHPAE28002256.820↓9.64.72473813.6318893
104M4yHPAE6001806.9229.7512↓54718.6↑2111054↓
105M1y 1mNHPAE20001276.52311.3↑5.7236276.4348865
106F9yNHPAE14502106.9229.74.82172019↑18↓7585
107M4y↑↑HPAE13503007.316↓9.95.19↓4884.1277382
108F3y 11mHPAE8573057.316↓9.74.71479617.533.957↓72
109M1y 1mNHPAE15003206.620↓9.55.14172723.8↑17.6↓10166
110F7y 10mNHPAE7222307.215↓104.343110892860↓94
111F6y 3mNHPAE7501737.116↓9.95.22668611.916.6↓8783
112F4y 1mNHPAE20001756.516↓9.54.64290519.1↑337290
113F3y 6mNHPAE24001987.12310.14.610↓66916.212↓9881
114M11yNHPAE22993007.420↓9.64.42065017.514↓7983
115M8y 1mHPAE1800266720↓10.44.14449513.8297495
116F2y 10mNHPAE190097720↓10.45.32748317.53065106
117F5y 7mNHPAE1415139717↓10.25.1177411730.57272
118F2y 11mNHPAE14502836.3219.33.99443517.53062↓61
119F3y 4mNHPAE21001807.63410.9↑5.54760617.5207370
120M1y 6mNHPAE9503056.618↓10.15.910↓19015.12961↓53↓
121F23y 9mNCPKUDE23515457.6249.52.5↓32421142410985
122F28y 1m↑↑CPKUDE4376247.6249.53.38012891741↑6569
123M22y 7mNCPKUDE4435166.1↓218.93.821298217287687
124M10y 4mNMPKUD/TE9222207.72611↑44243512277186
125F17y 2mNCPKUDE2459907.3309.86.5↑283635.82411275
126F19y 19mNMPKUDE3128827.53510.22.2↓4138717.5339573
127M8y 2m↑↑HPAE21002907.52110.14.62379010.442 ↑7093
128M13y 4mNCPKUDE1822826.73210.14.54439417.2309185
129M19y 11m↑↑CPKUDE4923967.1299.84.72944511.8297669
130F27y 9mNCPKUDE3655166.6248.73.440106917.5408585
131F12y 7m↑↑MPKUD/TE8232796.5219.44.13238914327465
132M10y 4mNMPKUD/TE9222227.5269.83.85543712277086
133M18y 5mCPKUDE2561956.9349.84.31726910.2287674
134F42y 1mMPKUD/TE8557567299.64.336614.73511668
135F11y 5m↑↑MPKUD/TE20521807.32110.33.87242010.3389864
136M23y 5mCPKUDL4527357.8299.74.21820917208188
137F25y 4mNCPKUD/TE7308037.4319.92.8422294.7276989
138F21y11mNMPKUD/TE30002327.5269.93.73039411.1287082
139F17y 10mNMPKUD/TE8024367.5299.53.42257117.5229872
140F14yNCPKUDE4132047.632104.14372711.1318668
141M13yNCPKUDE2604498371045090517.53310185
142F10y 7m↑↑CPKUDE1484767.5249.94.12960513.72711367
143M10y 2mNMPKUD/TE16002456.82510.24.33969916.1276887
144F3y 5m↑↑CPKUDE2641696.62210.45.2271247268980
145M2y 8mNCPKUDE165766.62410.54.2251057248280
146F1y 5mNCPKUDE1742487.22410.44.920877239565
147F5y 7mNHPAE19002457.52410.14.81838210.1209772
148F18y 10mHPAE28002607.4309.74175203.9318670
149M7y 11mNHPAE14502357.52110.84.52173017207775
150M11y 11mNHPAE23002807.4249.64.9145098.52013285
151F8y 6mNHPAE11692706.8219.54.54835641.5209069
152M1y 6mNHPAE9501396.8229.74303429.6297870
153M3y 3mNHPAE16421926.6229.45.21953726247464
154F23y 2mNCPKUDL45112727.43510.83.6253624.2238191
155F37y 3mCPKUDL2995767.22510.33.323228208567
156M16y 5mNHPAE33020007.12210.13.42264015337487

Characteristics of Hyperphenylalaninaemia patients with altered values of the biochemical parameters studied.

P: patient; M: male; F: female; BMI: body mass index; N: normal; ↑overweight, ↑↑ obesity, CPKU: classic phenylketonuria; MPKU: mild-moderate PKU; MHPA: moderate hyperphenylalaninaemia; Tre:Treatment; D: Dietetic; T: BH4 therapy; TD: time of diagnosis; E: Early; L:late; Phe tol: Phenylalanine tolerance; Prot: Total protein total; Prealb: Prealbumin; Fer: Ferritine.

Total protein, Ca, P, B12, ferritin, and Zn levels were in the normal range in almost all patients. Nevertheless, Palb was decreased in 34.6% of patients (74% from PKU) being the 94.4% of them below 18 years old and having the 96.3% an adequate adherence to treatment. Se was found to be diminished in 25% of patients, 76.9% of them with classic PKU but only in 2.56% of patients under BH4 treatment. An adequate intake of Ca, P and 25-OHD is necessary for optimal bone accretion but it is not enough for bone normal development because several studies have showed that protein intake deficiency can influence the bone mass [6,7]. Our patients generally had adequate levels of Ca and P, but there were found low levels of 25-OHD in 14% of them. The 25-OHD was found altered in 14% of total patients. No deficiency of folic acid was found in our cohort, but was found to be above the upper limit in 39% of patients, 65.6% with classic PKU and 82% of them with adequate adherence to diet. Patients treated with BH4 presented lower levels of B12 with respect to non-treated (536 vs 694 pg/mL, p: 0.0094). No other anthropometric parameters were found to be correlated with any variable in our study. We noted in our study a high percentage of PKU patients with good adherence to diet with Prealbumin deficiency and total protein normal. Also a high percentage of PKU patients with Se deficiency had folic acid increase. On the contrary, only el 2.56% de patients under BH4 treatment showed Se deficiency.
Specifications Table
Subject areaMetabolic diseases
More specific subject areaVitamins and minerals in phenylketonuria
Type of dataTable
How data was acquiredBy clinical history
Data formatAnalyzed data
Experimental factorsNone applied
Experimental features-Tandem mass-spectrometry and standard procedures of laboratory
Data source locationPKU patients from three Spanish Centers: Hospital Universitario La Fe-Valencia, Hospital Universitario de Cruces-Basque Country and Hospital Clínico Universitario de Santiago-Galicia.
Data accessibilityData is supplied in this article
Value of the data
A high percentage of selenium deficits as well as a high percentage of folic acid overloads are detected in PKU patients treated, which should lead us to reflect on whether to adjust international standards supplements formulated milks.
  7 in total

Review 1.  Micronutrient status in phenylketonuria.

Authors:  M Robert; J C Rocha; M van Rijn; K Ahring; A Bélanger-Quintana; A MacDonald; K Dokoupil; H Gokmen Ozel; A M Lammardo; P Goyens; F Feillet
Journal:  Mol Genet Metab       Date:  2013-09-19       Impact factor: 4.797

2.  Vitamin B12 deficiency in adolescents and young adults with phenylketonuria.

Authors:  W B Hanley; A Feigenbaum; J T Clarke; W Schoonheyt; V Austin
Journal:  Lancet       Date:  1993-10-16       Impact factor: 79.321

3.  Vitamin and mineral status in patients with hyperphenylalaninemia.

Authors:  Vanesa Crujeiras; Luis Aldámiz-Echevarría; Jaime Dalmau; Isidro Vitoria; Fernando Andrade; Iria Roca; Rosaura Leis; Ana Fernandez-Marmiesse; María L Couce
Journal:  Mol Genet Metab       Date:  2015-06-27       Impact factor: 4.797

4.  Risk factors for developing mineral bone disease in phenylketonuric patients.

Authors:  Alicia Mirás; M Dolores Bóveda; María R Leis; Antonio Mera; Luís Aldámiz-Echevarría; José R Fernández-Lorenzo; José M Fraga; María L Couce
Journal:  Mol Genet Metab       Date:  2013-01-05       Impact factor: 4.797

5.  Poor zinc and selenium status in phenylketonuric children and adolescents in Brazil.

Authors:  Junaura Rocha Barretto; Luciana Rodrigues Silva; Maria Efigênia Leite; Ney Boa-Sorte; Helena Pimentel; Antonio Conceição Purificação; Gildasio Carvalho; Maria Inês M M Fontes; Tatiana Amorim
Journal:  Nutr Res       Date:  2008-03       Impact factor: 3.315

6.  Phenylalanine hydroxylase deficiency: diagnosis and management guideline.

Authors:  Jerry Vockley; Hans C Andersson; Kevin M Antshel; Nancy E Braverman; Barbara K Burton; Dianne M Frazier; John Mitchell; Wendy E Smith; Barry H Thompson; Susan A Berry
Journal:  Genet Med       Date:  2013-10-10       Impact factor: 8.822

Review 7.  Causal assessment of dietary acid load and bone disease: a systematic review & meta-analysis applying Hill's epidemiologic criteria for causality.

Authors:  Tanis R Fenton; Suzanne C Tough; Andrew W Lyon; Misha Eliasziw; David A Hanley
Journal:  Nutr J       Date:  2011-04-30       Impact factor: 3.271

  7 in total
  3 in total

1.  Influence of phenylketonuria's diet on dimethylated arginines and methylation cycle.

Authors:  Fernando Andrade; Olalla López-Suárez; Marta Llarena; María L Couce; Luis Aldámiz-Echevarría
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

Review 2.  Dietary intervention in the management of phenylketonuria: current perspectives.

Authors:  Júlio César Rocha; Anita MacDonald
Journal:  Pediatric Health Med Ther       Date:  2016-12-01

3.  The effects of low protein products availability on growth parameters and metabolic control in selected amino acid metabolism disorders patients.

Authors:  Bedour Handoom; Eman Megdad; Dana Al-Qasabi; Munirah Al Mesned; Reem Hawary; Samir Al-Nufiee; Zuhair Al-Hassnan; Moeenaldeen Dia Alsayed; Abdelmoneim Eldali
Journal:  Int J Pediatr Adolesc Med       Date:  2018-06-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.